Sightbox Acquired, a MAJOR Dry Eye Lawsuit, & ACUVUE® VITA® for Astigmatism

Sightbox Acquired, a MAJOR Dry Eye Lawsuit, & ACUVUE® VITA® for Astigmatism

Welcome to what’s trending in eye care, brought to you by IntroWellness.com and OptomEyesLife! I’m Dr. Amanda Rights, here to bring you the news!

If the eye care industry was playing a game of Monopoly, Johnson & Johnson Vision would be winning

As I reported last month, J&J Vision recently acquired Abbott Medical Optics and TearScience Inc. Now, through the acquisition of Sightbox, this vision care leader is aiming to help connect more patients with eye care professionals while addressing the growing consumer preference for e-commerce solutions.

What’s Sightbox?

Sightbox is a membership-based subscription contact lens service in the United States. Their service helps contact lens wearers schedule a comprehensive eye exam and contact lens evaluation, as well as obtain an annual supply of contact lenses.

This is how Sightbox works
Source: Sightbox.com

How is Sightbox different from other contact lens subscription services?

  1. Sightbox requires members to schedule an annual comprehensive eye exam in order to receive contact lenses. Routine examinations by a licensed eye care professional are necessary to ensure your eye health and well-being.
  2. They offer daily, 2-week, and monthly soft disposable contact lenses. This includes astigmatism and multifocal options from all major manufacturers.
  3. On behalf of their members, Sightbox works directly with eye care offices to schedule an appointment, pay for the examination, and fill contact lens prescriptions through monthly shipments.

A MAJOR dry eye drug lawsuit was just filed…

Shire (the maker of Xiidra®) is suing Allergan (the maker of Restasis®) for allegedly scheming to prevent doctors from prescribing its new treatment for dry eye disease.

The lawsuit follows Allergan’s announcement in early September that it transferred its Restasis patents to the Saint Regis Mohawk Tribe, whose sovereign status could limit legal challenges. The Tribe subsequently agreed to license the patents back to Allergan.

Xiidra
Source: Xiidra.com

What’s Shire saying?

Shire says that Allergan has blocked access to Xiidra® for patients with Part D Medicare plans by keeping a nearly $1.5 billion monopoly on the Medicare Part D market via “employing egregiously anti-competitive and unlawful tactics.” Shire states that they offered deep discounts on Xiidra® in a bid to be covered by Medicare Part D plans, but were denied due to Allergan’s “bundled discounts and exclusive dealings,” among other things.

Restasis MultiDose
Source: Restasis.com

What’s Allergan saying?

Allergan says that they have complied with all Medicare Part D guidelines and haven’t broken any laws. They also say that “competition in the chronic dry eye therapeutic market has driven pricing down for patients.” This would be nice since “low prices” and “prescription medications” aren’t typically found in the same sentence!

October 12th was World Sight Day

World Sight Day (WSD) is an annual day of awareness to focus global attention on blindness and vision impairment. It is coordinated by the International Agency for the Prevention of Blindness under the VISION 2020 Global Initiative.

World Sight Day Challenge 2017
Source: Givingsight.org

The World Sight Day Challenge is a major fundraising campaign coordinated by Optometry Giving Sight designed to raise funds for projects that train local eye care professionals, establish vision centers, and deliver eye care services and glasses. Optometry Giving Sight is the only global fundraising initiative that specifically targets the prevention of blindness and impaired vision due to uncorrected refractive error.

This year, they helped to raise funds in support of children’s eye health. There are millions of children around the world whose futures depend on being able to access an eye exam and a pair of glasses.   

ACUVUE® VITA® for Astigmatism is now available!

What’s ACUVUE® VITA®?

ACUVUE® VITA® is Acuvue’s first monthly contact lens (more about this below). It combines two technologies:

1) HydraMax™ Technology

This is a non-coated, silicone hydrogel formulation balanced to help maximize and maintain hydration throughout the life of the lens for reliable, exceptional comfort all month long. In a clinical study, more than 7 out of 10 wearers reported that ACUVUE® VITA® for Astigmatism delivers exceptional comfort at weeks 1, 2, 3 and 4!

2) BLINK STABILIZED™ Design

This design works naturally with your eyelids, helping to keep your contact lens in the correct position. In a clinical study, 75% of wearers reported crisp, clear, stable vision, even with head and eye movements.

ACUVUE® VITA® for Astigmatism also provides Class I UV protection, blocking approximately 93% of UVA and 99% of UVB rays.

Acuvue Vita for Astigmatism
Source: Acuvue.com

In case you were wondering…

ACUVUE® OASYS® is not a monthly lens. It has a 2-week (14-day) replacement schedule but is commonly mistaken as a monthly lens. This misunderstanding can lead to lens overwear and an increased risk of developing an eye infection.

Curious if you’re a candidate for the new ACUVUE® VITA® for Astigmatism contact lenses? Schedule an appointment with your local eye care professional today!

That’s all for what’s trending in eye care! Subscribe to our newsletter for more updates coming soon.

Leave a Reply

Be the First to Comment!

Notify of
wpDiscuz